Virtual Event – Trace Amine-Associated Receptor 1 (TAAR1): A Potential New Target For The Treatment of Schizophrenia
Speakers Dennis Pabis, PharmD, BCPP; Nneka Okonkwor, PharmD, MBA; and Hasib H. Bhojwani, MD are employees of Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC)